{"product_id":"update-on-neuromonitoring","title":"Update on Neuromonitoring","description":"\u003cmeta charset=\"utf-8\"\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eEverything you can learn about neuromonitoring and the latest development in research from the world's top scientists. Streaming is available on request.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eMore than 24 hours of content in english.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cb\u003eProgram :\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eWelcome to Roma: A city full of brain(s) - \u003cstrong\u003eM. Antonellli (Rome, Italy)\u003c\/strong\u003e\u003cbr\u003eWelcome to the meeting : A look inside the skull - \u003cstrong\u003eJ-L. Vincent (Brussels, Belgium)\u003c\/strong\u003e\u003cbr\u003eNeuromonitoring: Many questions without answers - \u003cstrong\u003eN Stocchetic (Milan, Italy)\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eBasic Concepts :\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eCerebral blood flow, cerebal perfusion pressure, autoregulation - \u003cstrong\u003eG Citerio (Monza, Italy) \u003c\/strong\u003e\u003cbr\u003eCerebral oxygen delivery and consumption - \u003cstrong\u003eN Stoccheti (Milan, Italy) \u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eE\u003c\/strong\u003energy metabolism - \u003cstrong\u003eM Oddo (Lausanne, Switzerland) \u003c\/strong\u003e\u003cbr\u003eNeuroinflammation and neuromodulation - \u003cstrong\u003eT Sharshar (Garches, France)\u003c\/strong\u003e\u003cbr\u003eMechanisms of brain damage after trauma - \u003cstrong\u003eM Oddo (Lausanne, Switzerland) \u003c\/strong\u003e\u003cbr\u003eBrain glucose metabolism -\u003cstrong\u003e P Le Roux (Philadelphia, USA)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eFlow delivery, adequacy of perfusion \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eNon-invasive: indirect measures, Doppler techniques - \u003cstrong\u003eP Vespa (Los Angeles, USA) \u003c\/strong\u003e\u003cbr\u003eInvasive methods - \u003cstrong\u003eG Citerio (Monza, Italy)\u003c\/strong\u003e\u003cbr\u003eMonitoring autoregulation - \u003cstrong\u003eP Horn (Berlin, Germany)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eCerebral blood flow and oxygenation (ctnd)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eMicrocirculation - \u003cstrong\u003eF Taccione (Brussels, Belgium)\u003c\/strong\u003e\u003cbr\u003eMonitoring brain oxygen - \u003cstrong\u003eP Le roux (Philadelphia, USA)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eICP Monitoring \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIndications and methods -\u003cstrong\u003e G Citerio (Monza, Italy)\u003c\/strong\u003e\u003cbr\u003eInterpretation -\u003cstrong\u003e N Stocchetti (Milan, Italy)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eCerebral oxygen availability \u003cbr\u003e\u003cem\u003eInvasive \u003c\/em\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eBrain PO2 - \u003cstrong\u003eP Andrews (Edinburgh, UK) \u003c\/strong\u003e\u003cbr\u003eSiO2 - \u003cstrong\u003eN Stocchetti (Milan, Italy) \u003c\/strong\u003e\u003cbr\u003eCerebral microdialysis - \u003cstrong\u003eM Oddo (Lausanne, Switzerland) \u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eNon Invasive \u003c\/em\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003e\u003c\/strong\u003eNIRS in neurologic patients - \u003cstrong\u003eG Citerio (Monza, Italy) \u003c\/strong\u003e\u003cbr\u003eNIRS in cardiac surgical patients - \u003cstrong\u003eM Hartley (Blackpool, UK)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eCerebral metabolism \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eNeurological examination of the comatose patient - \u003cstrong\u003eT Sharshar (Garches, France) \u003c\/strong\u003e\u003cbr\u003eBrain specific biomakers ? - \u003cstrong\u003eR Stevens (Baltimore, USA)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eElectrical activity \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eEEG: Intermittent or continuous -\u003cstrong\u003e M Oddo (Lausanne, Switzerland) \u003c\/strong\u003e\u003cbr\u003eQuantitative EEG and evoked potentials - \u003cstrong\u003eP Vespa (Los Angeles, USA) \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eBrain imaging \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eCT-scan - \u003cstrong\u003eP Horn (Berlin, Germany) \u003c\/strong\u003e\u003cbr\u003eMRI in cardiac arrest - \u003cstrong\u003eR Stevens (Baltimore, USA) \u003c\/strong\u003e\u003cbr\u003eMRI in critical illness encephalopathy - \u003cstrong\u003eT Sharshar (Garches, France)\u003c\/strong\u003e\u003cbr\u003eMRI in traumatic brain injury - \u003cstrong\u003eR Stevens (Baltimore, USA)\u003c\/strong\u003e\u003cbr\u003eWe need neurological examination when the patient is well monitored \u003cbr\u003e\u003cstrong\u003ePro - N Stocchetti (Milan, Italy) \u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eCon - P Vespa (Los Angeles, USA)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003ePrognosis \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eHow monitoring can help assess prognosis - \u003cstrong\u003eT sharshar (Baltimore, USA) \u003c\/strong\u003e\u003cbr\u003ePrognosis in trauma - \u003cstrong\u003eR Stevens (Baltimore - USA)\u003c\/strong\u003e\u003cbr\u003ePrognosis in cardiac arrest - \u003cstrong\u003eF Taccone (Brussels, Belgium)\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eRound table discussion \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eWhat kinds of clinical trial do we need ? \u003cbr\u003e\u003cstrong\u003eP Horn (Berlin Germany), R Stevens (Baltimore, USA) P Andrews (Edinburgh, UK) \u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eP Vespa (Los Angeles, USA), P Le Roux (Philadelphia, USA)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eAdvanced neuromonitoring \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eWhat is the difference ? - \u003cstrong\u003eP Andrews (Edinburgh, UK)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eRound table discussion \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIntegration - Multimodal monitoring - Bioinformatics -\u003cstrong\u003e P Andrews (Edinburgh, UK), G Citterio (Monza, Italy), P Horn (Berlin, Germany), P Le Roux (Philadelphia, USA)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003ePratical cases \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eHead trauma - \u003cstrong\u003eG Citterio (Monza, Italy) \u003c\/strong\u003e\u003cbr\u003eHead trauma 2 - \u003cstrong\u003eP Le Roux (Philadelphia, USA) \u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eSubarachnoid hemorrhage - M Oddo (Lausanne, Switzerland)\u003c\/strong\u003e\u003cbr\u003eHypothermia -\u003cstrong\u003e P Andrews (Edinburgh, UK)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eConclusions \u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eThe take messages\u003c\/p\u003e","brand":"DVDCongress","offers":[{"title":"Default Title","offer_id":32574234099756,"sku":"","price":99.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0331\/9188\/6892\/products\/neuromonitoring-roma-sf.png?v=1585230864","url":"https:\/\/e-onescience.org\/products\/update-on-neuromonitoring","provider":"DVDCongress","version":"1.0","type":"link"}